Theravance Biopharma
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
WHITESIDES GEORGE M director
 Ordinary Shares 4,000 N/A N/A
Purchase
FORE HENRIETTA director
 Ordinary Shares 6,000 N/A N/A
Sale
HAUMANN BRETT K officer: Chief Medical Officer
 Ordinary Shares 424 N/A N/A
Sale
HAUMANN BRETT K officer: Chief Medical Officer
 Ordinary Shares 13,576 N/A N/A
Sale
SHAFER BRADFORD J officer: EVP, Gen. Counsel, Sec..
 Ordinary Shares 26,829 N/A N/A
Sale
HAUMANN BRETT K officer: Chief Medical Officer
 Ordinary Shares 4,491 N/A N/A
Sale
SHAFER BRADFORD J officer: EVP, Gen. Counsel, Sec..
 Ordinary Shares 37,078 N/A N/A
Sale
SHAFER BRADFORD J officer: EVP, Gen. Counsel, Sec..
 Ordinary Shares 4,870 N/A N/A
Sale
HAUMANN BRETT K officer: Chief Medical Officer
 Ordinary Shares 9,509 N/A N/A
Sale
SHAFER BRADFORD J officer: EVP, Gen. Counsel, Sec..
 Ordinary Shares 7,174 N/A N/A
Purchase
GLAXOSMITHKLINE PLC 10 percent owner
 Ordinary Shares 1,301,015 N/A N/A
Purchase
GLAXOSMITHKLINE PLC 10 percent owner
 Ordinary Shares 44,574 N/A N/A
Purchase
MALKIEL BURTON G director
 Ordinary Shares 10,000 N/A N/A
Purchase
LEE JUNNING officer: Sr. VP, Technical Oper..
 Ordinary Shares 9,000 N/A N/A
Purchase
WINNINGHAM RICK E director, officer: Chief Execut..
 Ordinary Shares 16,860 N/A N/A
Purchase
GALA RENEE D officer: SVP, Chief Financial O..
 Ordinary Shares 5,000 N/A N/A
Purchase
WINNINGHAM RICK E director, officer: Chief Execut..
 Ordinary Shares 63,140 N/A N/A
Purchase
GALA RENEE D officer: SVP, Chief Financial O..
 Ordinary Shares 5,000 N/A N/A

Showing 50 to 68 of 68 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: